Bioassay of phenformin for possible carcinogenicity.

Corporate Authors: United States. National Cancer Institute. Carcinogen Bioassay and Program Resources Branch
Published: Dept. of Health, Education, and Welfare, Public Health Service, National Institutes of Health, National Cancer Institute, Division of Cancer Cause and Prevention, Carcinogenesis Program, Carcinogen Bioassay and Program Resources Branch,
Publication Dates: 1977.
Call Number: R730.23/N277/